Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Infection01:20

Infection

11.9K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
11.9K
Methods for Controlling Microbial Growth01:29

Methods for Controlling Microbial Growth

1.5K
Microbial growth control refers to various methods employed to inhibit, reduce, or eliminate microorganisms to ensure safety and hygiene across different settings. These methods are categorized based on the target environment and the level of microbial control required.Biocides are versatile agents designed to control microorganisms by either inhibiting their growth or outright killing them. These agents work through various physical, chemical, mechanical, or biological mechanisms. The...
1.5K
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

524
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
524
Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

788
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
788
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

722
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
722
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

2.6K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current challenges in real-world management of Clostridioides difficile infection.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2025
Same author

Two concurrent nationwide healthcare-associated outbreaks of <i>Burkholderia cepacia</i> complex linked to product contamination, UK and Ireland, 2010-2023 - ADDENDUM.

Infection control and hospital epidemiology·2025
Same author

Two concurrent nationwide healthcare-associated outbreaks of <i>Burkholderia cepacia</i> complex linked to product contamination, UK and Ireland, 2010-2023.

Infection control and hospital epidemiology·2025
Same author

Choline Metabolism to the Proatherogenic Metabolite Trimethylamine Occurs Primarily in the Distal Colon Microbiome In Vitro.

Metabolites·2025
Same author

Using nutrition to help recovery from infections.

Current opinion in gastroenterology·2024
Same author

Distribution of <i>Clostridioides difficile</i> ribotypes and sequence types across humans, animals and food in 13 European countries.

Emerging microbes & infections·2024
Same journal

Climate adaptation and biodiversity shape West Nile virus risk in cities.

Nature reviews. Microbiology·2026
Same journal

Climate factors and evolution drive cholera surges in Dhaka.

Nature reviews. Microbiology·2026
Same journal

Climate change boosts Salmonella antimicrobial resistance.

Nature reviews. Microbiology·2026
Same journal

Reframing risk assessment for malaria elimination in a changing climate.

Nature reviews. Microbiology·2026
Same journal

Bacterial vesicles protect the membrane during polymyxin stress.

Nature reviews. Microbiology·2026
Same journal

Fermented food microbiome: influence on oral and gut microbiota, and human health.

Nature reviews. Microbiology·2026
See all related articles

Related Experiment Video

Updated: Jan 16, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

13.1K

Clostridioides difficile pathogenesis and control.

Caroline H Chilton1,2, Virginie Viprey3,4, Charmaine Normington3,5

  • 1Leeds Institute of Medical Research, University of Leeds, Leeds, UK. C.h.chilton@leeds.ac.uk.

Nature Reviews. Microbiology
|October 2, 2025
PubMed
Summary
This summary is machine-generated.

Clostridioides difficile infection (CDI) poses a global health challenge due to rising rates and treatment difficulties. Understanding gut microbiota

More Related Videos

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

39.9K
A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.3K

Related Experiment Videos

Last Updated: Jan 16, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

13.1K
Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

39.9K
A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.3K

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Gastroenterology

Background:

  • Clostridioides difficile infection (CDI) presents a significant global health burden, impacting patient mortality, morbidity, and healthcare economics.
  • Epidemiological shifts in C. difficile, amplified by the COVID-19 pandemic and antimicrobial resistance, have led to increased infection rates.
  • C. difficile poses diagnostic and therapeutic challenges due to its spore-forming ability, asymptomatic persistence, and expression of virulence factors like toxins.

Purpose of the Study:

  • To review the evolving epidemiology of C. difficile infection.
  • To discuss advancements in understanding CDI pathogenesis, antibiotic resistance, and diagnostic challenges.
  • To explore the critical role of gut microbiota dysbiosis in CDI and evaluate novel microbiota-based therapies.

Main Methods:

  • Literature review of epidemiological data and clinical studies on C. difficile infection.
  • Analysis of research on C. difficile virulence factors, spore formation, and host-pathogen interactions.
  • Synthesis of findings on the impact of gut microbiota dysbiosis and emerging microbiota therapies for CDI.

Main Results:

  • CDI rates have increased due to various clinical pressures, including pandemics and antimicrobial use.
  • Gut microbiota dysbiosis, frequently induced by antibiotics, facilitates C. difficile colonization and pathogenesis.
  • Novel microbiota-based therapies show promise for treating and preventing CDI.

Conclusions:

  • Effective management of CDI requires addressing its changing epidemiology and complex pathogenesis.
  • Restoring gut microbiota balance is a key strategy for combating C. difficile infection.
  • Further research into microbiota therapies is essential for developing innovative CDI treatments.